Advanced search
1 file | 1.51 MB Add to list

The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia : results of a multicenter study

(2018) CLINICAL CANCER RESEARCH. 24(20). p.5048-5057
Author
Organization
Keywords
B-CELL RECEPTOR, ZAP70 MESSENGER-RNA, GENE-EXPRESSION, IG, LIGATION, CLL, QUANTIFICATION, STIMULATION, REVEALS

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.51 MB

Citation

Please use this url to cite or link to this publication:

MLA
Stamatopoulos, Basile et al. “The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia : Results of a Multicenter Study.” CLINICAL CANCER RESEARCH 24.20 (2018): 5048–5057. Print.
APA
Stamatopoulos, B., Smith, T., Crompot, E., Pieters, K., Clifford, R., Mraz, M., Robbe, P., et al. (2018). The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia : results of a multicenter study. CLINICAL CANCER RESEARCH, 24(20), 5048–5057.
Chicago author-date
Stamatopoulos, Basile, Thomas Smith, Emerence Crompot, Karlien Pieters, Ruth Clifford, Marek Mraz, Pauline Robbe, et al. 2018. “The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia : Results of a Multicenter Study.” Clinical Cancer Research 24 (20): 5048–5057.
Chicago author-date (all authors)
Stamatopoulos, Basile, Thomas Smith, Emerence Crompot, Karlien Pieters, Ruth Clifford, Marek Mraz, Pauline Robbe, Adam Burns, Adele Timbs, David Bruce, Peter Hillmen, Nathalie Meuleman, Philippe Mineur, Radu Firescu, Marie Maerevoet, Virginie De Wilde, Andre Efira, Jan Philippé, Bruno Verhasselt, Fritz Offner, David Sims, Andreas Heger, Helene Dreau, and Anna Schuh. 2018. “The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia : Results of a Multicenter Study.” Clinical Cancer Research 24 (20): 5048–5057.
Vancouver
1.
Stamatopoulos B, Smith T, Crompot E, Pieters K, Clifford R, Mraz M, et al. The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia : results of a multicenter study. CLINICAL CANCER RESEARCH. 2018;24(20):5048–57.
IEEE
[1]
B. Stamatopoulos et al., “The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia : results of a multicenter study,” CLINICAL CANCER RESEARCH, vol. 24, no. 20, pp. 5048–5057, 2018.
@article{8593794,
  author       = {Stamatopoulos, Basile and Smith, Thomas and Crompot, Emerence and Pieters, Karlien and Clifford, Ruth and Mraz, Marek and Robbe, Pauline and Burns, Adam and Timbs, Adele and Bruce, David and Hillmen, Peter and Meuleman, Nathalie and Mineur, Philippe and Firescu, Radu and Maerevoet, Marie and De Wilde, Virginie and Efira, Andre and Philippé, Jan and Verhasselt, Bruno and Offner, Fritz and Sims, David and Heger, Andreas and Dreau, Helene and Schuh, Anna},
  issn         = {1078-0432},
  journal      = {CLINICAL CANCER RESEARCH},
  keywords     = {B-CELL RECEPTOR,ZAP70 MESSENGER-RNA,GENE-EXPRESSION,IG,LIGATION,CLL,QUANTIFICATION,STIMULATION,REVEALS},
  language     = {eng},
  number       = {20},
  pages        = {5048--5057},
  title        = {The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia : results of a multicenter study},
  url          = {http://dx.doi.org/10.1158/1078-0432.CCR-18-0133},
  volume       = {24},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: